Gerber JG - Search Results

1

Delavirdine: clinical pharmacokinetics and drug interactions.

Tran JQ, Gerber JG, Kerr BM. Tran JQ, et al. Among authors: gerber jg. Clin Pharmacokinet. 2001;40(3):207-26. doi: 10.2165/00003088-200140030-00005. Clin Pharmacokinet. 2001. PMID: 11327199 Review.

2

Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.

Fichtenbaum CJ, Gerber JG. Fichtenbaum CJ, et al. Among authors: gerber jg. Clin Pharmacokinet. 2002;41(14):1195-211. doi: 10.2165/00003088-200241140-00004. Clin Pharmacokinet. 2002. PMID: 12405866 Review.

3

Using pharmacokinetics to optimize antiretroviral drug-drug interactions in the treatment of human immunodeficiency virus infection.

Gerber JG. Gerber JG. Clin Infect Dis. 2000 Jun;30 Suppl 2:S123-9. doi: 10.1086/313857. Clin Infect Dis. 2000. PMID: 10860896 Review.

4

Combination therapy with indinavir, ritonavir, and delavirdine and nucleoside reverse transcriptase inhibitors in patients with HIV/AIDS who have failed multiple antiretroviral combinations.

Grodesky M, Acosta EP, Fujita N, Mason S, Gerber JG. Grodesky M, et al. Among authors: gerber jg. HIV Clin Trials. 2001 May-Jun;2(3):193-9. doi: 10.1310/LJ7M-82QX-5QJJ-1R6R. HIV Clin Trials. 2001. PMID: 11590527 Clinical Trial.

5

Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.

Wu H, Huang Y, Acosta EP, Park JG, Yu S, Rosenkranz SL, Kuritzkes DR, Eron JJ, Perelson AS, Gerber JG. Wu H, et al. Among authors: gerber jg. J Pharmacokinet Pharmacodyn. 2006 Aug;33(4):399-419. doi: 10.1007/s10928-006-9006-4. Epub 2006 Apr 1. J Pharmacokinet Pharmacodyn. 2006. PMID: 16583266

6

Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction.

Wyles DL, Gerber JG. Wyles DL, et al. Among authors: gerber jg. Clin Infect Dis. 2005 Jan 1;40(1):174-81. doi: 10.1086/426021. Epub 2004 Dec 2. Clin Infect Dis. 2005. PMID: 15614709

7

Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers.

Glesby MJ, Aberg JA, Kendall MA, Fichtenbaum CJ, Hafner R, Hall S, Grosskopf N, Zolopa AR, Gerber JG; Adult AIDS Clinical Trials Group A5159 Protocol Team. Glesby MJ, et al. Among authors: gerber jg. Clin Pharmacol Ther. 2005 Aug;78(2):143-53. doi: 10.1016/j.clpt.2005.04.005. Clin Pharmacol Ther. 2005. PMID: 16084849 Clinical Trial.

8

Therapeutic drug monitoring in the treatment of HIV-infection.

Gerber JG, Acosta EP. Gerber JG, et al. J Clin Virol. 2003 Jul;27(2):117-28. doi: 10.1016/s1386-6532(03)00033-7. J Clin Virol. 2003. PMID: 12829033 Review.

9

Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistance.

Wu H, Huang Y, Acosta EP, Rosenkranz SL, Kuritzkes DR, Eron JJ, Perelson AS, Gerber JG. Wu H, et al. Among authors: gerber jg. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):272-83. doi: 10.1097/01.qai.0000165907.04710.da. J Acquir Immune Defic Syndr. 2005. PMID: 15980686

10

The pharmacology of antiretroviral nucleoside and nucleotide reverse transcriptase inhibitors: implications for once-daily dosing.

Back DJ, Burger DM, Flexner CW, Gerber JG. Back DJ, et al. Among authors: gerber jg. J Acquir Immune Defic Syndr. 2005 Aug 1;39 Suppl 1:S1-23, quiz S24-25. doi: 10.1097/01.qai.0000168882.67942.3f. J Acquir Immune Defic Syndr. 2005. PMID: 15990598 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters